- Erratum
- Open access
- Published:
Erratum To: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
Molecular Cancer volume 13, Article number: 183 (2014)
References
Heng L, Gan Y, Runlin S, Bin L, Xianguo C, Ding X, Haibing X, Xiaolin G, Wei G, Zhangqun Y, Wei X, Hua X: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy. Molecular Cancer. 2014, 13: 8- 10.1186/1476-4598-13-8
Author information
Authors and Affiliations
Corresponding authors
Additional information
The online version of the original article can be found at 10.1186/1476-4598-13-8
Heng Li, Gan Yu contributed equally to this work.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
Rights and permissions
Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Li, H., Yu, G., Shi, R. et al. Erratum To: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy. Mol Cancer 13, 183 (2014). https://doi.org/10.1186/1476-4598-13-183
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/1476-4598-13-183